Cited by 1,052Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects

The DOI matches its Crossref record; 64 of the 68 references it cites were found in a registry or an index.

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Glass, M, Faull, R.L.M, Dragunow, M·1997·Neuroscience

DOI 10.1016/s0306-4522(96)00428-9

Open this paper in CoChat — free account

Abstract

The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB

Integrity signals

Registry

Crossref · 10.1016/s0306-4522(96)00428-9

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The Thalamus
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164
Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Laminar Organization of Thalamic Projections to the Rat Neocortex
Herkenham, M. A. (1980) · Science · doi:10.1126/science.7352263 · Cited by 595
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Health aspects of cannabis
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500

Show all 68 references

Research works printed but not linked: 9

Bidaut-Russell, 1989, Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, Adv. Biosci., 75, 165
Campbell, 1986, Delta-9-tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat detate gyrus, J. Pharmac. exp. Ther., 239, 941
Chen, 1993, Transient concentration of cannabinoid receptors in the cortex subplate zone during kitten post-natal development, Soc. Neurosci. Abstr., 19, 305
Devane, 1988, Determination and characterisation of a cannabinoid receptor in rat brain, Molec. Pharmac., 34, 605
Dewey, 1972, The effects of chronic administration of trans-delta-9-tetrahydorcannibinol on behaviour and the cardiovascular system of dogs, Archs int. Pharmacodyn. Thér., 198, 118
Edery, 1972, Structure activity relationships in the tetrahydrocanabinol species, Arzneimittel-Forshch., 22, 1995
Howlett, 1985, Cannabinoid inhibition of adenylate cyclase. Biochemistry of response in neuroblasta cell membrane, Molec. Pharmac., 27, 429
Howlett, 1986, Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs, Molec. Pharmac., 29, 307
Mendelson, 1976, Operant acquisition of marijuana by men, J. Pharmac. exp. Ther., 198, 42

Sorted by citations

Items 301–400 of 1,000

Neuroprotective potential of CB1receptor agonists in anin vitromodel of Huntington's disease
Scotter, E. L., Goodfellow, C. E., Graham, E. S., Dragunow, M., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00773.x · Cited by 66
Self-citation
Determination of endocannabinoids in nematodes and human brain tissue by liquid chromatography electrospray ionization tandem mass spectrometry
Lehtonen, M., Storvik, M., Malinen, H., Hyytiä, P., Lakso, M., Auriola, S. O. K., Wong, G., & Callaway, J. C. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.02.004 · Cited by 66
Basic neuroanatomy and neuropharmacology of cannabinoids
Breivogel, C. S., & Sim‐Selley, L. J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782760 · Cited by 71
Medical Cannabis in Children
Aran, A. A., & Cayam-Rand, D. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10386 · Cited by 70
Hemp for Headache
Russo, E. B. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n02_04 · Cited by 65
Does cannabis use affect prospective memory in young adults?
Bartholomew, J., Holroyd, S., & Heffernan, T. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106909 · Cited by 67
Functional Imaging Studies in Cannabis Users
Chang, L., & Chronicle, E. P. (2007) · The Neuroscientist · doi:10.1177/1073858406296601 · Cited by 65
Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder
Picchietti, D. L., Underwood, D. J., Farris, W. A., Walters, A. S., Shah, M., Dahl, R. E., Trubnick, L. J., Bertocci, M. A., Wagner, M., & Hening, W. A. (1999) · Movement Disorders · doi:10.1002/1531-8257(199911)14:6 · Cited by 290
Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset
Martinotti, G., Santacroce, R., Papanti, D., Elgharably, Y., Prilutskaya, M., & Corazza, O. (2017) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527316666170413101839 · Cited by 64
The collection and processing of human brain tissue for research
Waldvogel, H. J., Bullock, J. Y., Synek, B. J. L., Curtis, M. A., van Roon‐Mom, W., & Faull, R. L. M. (2008) · Cell and Tissue Banking · doi:10.1007/s10561-008-9068-1 · Cited by 64
Self-citation
Dysfunctional Prefrontal Cortical Network Activity and Interactions following Cannabinoid Receptor Activation
Kucewicz, M. T., Tricklebank, M. D., Bogacz, R., & Jones, M. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2970-11.2011 · Cited by 66
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Mason, N. L., Theunissen, E. L., Hutten, N. R. P. W., Tse, D. H. Y., Toennes, S. W., Stiers, P. L. J., & Ramaekers, J. G. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.003 · Cited by 64
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Hou, L., Rong, J., Haider, A., Ogasawara, D., Varlow, C., Schafroth, M. A., Mu, L., Gan, J., Xu, H., Fowler, C. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01459 · Cited by 63
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
Liu, C. S., Chau, S. A., Ruthirakuhan, M. T., Lanctôt, K. L., & Herrmann, N. (2015) · CNS Drugs · doi:10.1007/s40263-015-0270-y · Cited by 63
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
Koppel, J. L., Bradshaw, H. B., Goldberg, T. E., Khalili, H., Marambaud, P., Walker, M. J., Pazo, M. D. J. M., Gordon, M. L., Christen, E., & Davies, P. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-2 · Cited by 63
Building blocks of pain: the regulation of key molecules in spinal sensory neurones during development and following peripheral axotomy
Alvares, D., & Fitzgerald, M. (1999) · Pain · doi:10.1016/s0304-3959(99)00140-2 · Cited by 63
Cannabinoid-Mediated Disinhibition and Working Memory: Dynamical Interplay of Multiple Feedback Mechanisms in a Continuous Attractor Model of Prefrontal Cortex
Carter, E., & Wang, X.-J. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm103 · Cited by 64
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal
Silva, L., Black, R., Michaelides, M., Hurd, Y. L., & Dow-Edwards, D. L. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.02.005 · Cited by 65
Toxic effects of prenatal exposure to alcohol, tobacco and other drugs
Scott-Goodwin, A. C., Puerto, M., & Moreno, I. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.03.043 · Cited by 62
Cannabinoids Activate Monoaminergic Signaling to Modulate KeyC. elegansBehaviors
Oakes, M., Law, W. J., Clark, T., Bamber, B. A., & Komuniecki, R. W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3151-16.2017 · Cited by 62
A scoping review of the use of cannabidiol in psychiatric disorders
Kirkland, A. E., Fadus, M. C., Gruber, S. A., Gray, K. M., Wilens, T. E., & Squeglia, L. M. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114347 · Cited by 63
The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions
Schwitzer, T., Schwan, R., Angioï-Duprez, K., Ingster-Moati, I., Lalanne, L., Giersch, A., & Laprévote, V. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.002 · Cited by 66
Cannabis-Associated Psychosis
Leweke, F. M., Gerth, C. W., & tter, J. K. (2004) · CNS Drugs · doi:10.2165/00023210-200418130-00005 · Cited by 60
The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder
Jaggar, S., Sellaturay, S., & Rice, A. S. C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00621-1 · Cited by 60
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas
de Jesús, M. L., Hostalot, C., Garibi, J., Sallés, J., Meana, J. J., & Callado, L. F. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.007 · Cited by 59
Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC)
Bossong, M. G., Jansma, J. M., Bhattacharyya, S., & Ramsey, N. F. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.017 · Cited by 62
Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults
Cohen, M. A., Rasser, P. E., Peck, G., Carr, V. J., Ward, P. B., Thompson, P. M., Johnston, P., Baker, A., & Schall, U. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571100068x · Cited by 59
Binge-eating disorder: Clinical and therapeutic advances
Hutson, P. H., Balodis, I. M., & Potenza, M. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.002 · Cited by 62
“Brain over body”–A study on the willful regulation of autonomic function during cold exposure
Muzik, O., Reilly, K. T., & Diwadkar, V. A. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.01.067 · Cited by 68
Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
Kelly, R. L., Joers, V. L., Tansey, M. G., McKernan, D. P., & Dowd, E. (2020) · Molecules · doi:10.3390/molecules25030453 · Cited by 58
Hippocampal circuit dysfunction in psychosis
Knight, S., McCutcheon, R. A., Dwir, D., Grace, A. A., O’Daly, O., McGuire, P. K., & Modinos, G. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02115-5 · Cited by 61
Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco
Russo, E. B., Merzouki, A., Mesa, J. M., Frey, K. A., & Bach, P. J. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.03.029 · Cited by 58
Cell‐Penetrating and Neurotargeting Dendritic siRNA Nanostructures
Brunner, K., Harder, J., Halbach, T. S., Willibald, J., Spada, F., Gnerlich, F. A., Sparrer, K. M. J., Beil, A., Möckl, L., Bräuchle, C., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409803 · Cited by 58
Acute Δ9-Tetrahydrocannabinol-Induced Deficits in Reversal Learning: Neural Correlates of Affective Inflexibility
Egerton, A., Brett, R. R., & Pratt, J. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300715 · Cited by 57
Learning and Memory Performances in Adolescent Users of Alcohol and Marijuana: Interactive Effects
Mahmood, O. M., Jacobus, J., Bava, S., Scarlett, A., & Tapert, S. F. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.885 · Cited by 56
Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users – a multi-voxel pattern analysis
Cheng, H., Skosnik, P. D., Pruce, B., Brumbaugh, M., Vollmer, J. M., Fridberg, D. J., O’Donnell, B. F., Hetrick, W. P., & Newman, S. D. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114550354 · Cited by 56
Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates
de Jesús, M. L., Sallés, J., Meana, J. J., & Callado, L. F. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.024 · Cited by 56
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
Bukke, V. N., Moola, A., Villani, R., Serviddio, G., & Cassano, T. (2021) · Pharmaceuticals · doi:10.3390/ph14100965 · Cited by 55
Molecular Imaging Markers to Track Huntington’s Disease Pathology
Wilson, H., Micco, R. D., Niccolini, F., & Politis, M. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00011 · Cited by 55
Regular cannabis use is associated with altered activation of central executive and default mode networks even after prolonged abstinence in adolescent users: Results from a complementary meta-analysis
Blest‐Hopley, G., Giampietro, V., & Bhattacharyya, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.026 · Cited by 56
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Δ9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients
Berding, G., Müller-Vahl, K., Schneider, U., Gielow, P., Fitschen, J., Stuhrmann, M., Harke, H., Buchert, R., Donnerstag, F., Hofmann, M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.005 · Cited by 54
Long-term effects of cannabis on eye movement control in reading
Huestegge, L., Kunert, H. J., & Radach, R. R. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1769-z · Cited by 54
Quantitative Whole-Body Autoradiography: Past, Present and Future
McEwen, A., & Henson, C. (2015) · Bioanalysis · doi:10.4155/bio.15.9 · Cited by 54
The Effect of Chronic Cannabinoids on Broadband EEG Neural Oscillations in Humans
Skosnik, P. D., D’Souza, D. C., Steinmetz, A. B., Edwards, C. R., Vollmer, J. M., Hetrick, W. P., & O’Donnell, B. F. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.65 · Cited by 54
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced Suppression of Excitation in the Anterior Cingulate Cortex
Guo, B., Wang, J., Yao, H., Ren, K., Chen, J., Yang, J., Cai, G., Liu, H., Fan, Y., Wang, W., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx117 · Cited by 54
Acute effects of partial CB1 receptor agonists on cognition – A meta-analysis of human studies
Zhornitsky, S., Pelletier, J., Assaf, R., Giroux, S., Li, C.-S. R., & Potvin, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110063 · Cited by 54
SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents
de Bruin, N. M. W. J., Prickaerts, J., Lange, J. H. M., Akkerman, S., Andriambeloson, E., de Haan, M., Wijnen, J., Drimmelen, M. V., Hissink, E., Heijink, L., et al. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.01.010 · Cited by 54
The role of cannabinoids in pain modulation in companion animals
Miranda-Cortés, A. E., Mota‐Rojas, D., Crosignani, N., Casas-Alvarado, A., Martı́nez-Burnes, J., Olmos-Hernández, A. S., Mora‐Medina, P., Verduzco-Mendoza, A., & Hernández-Ávalos, I. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1050884 · Cited by 53
The Pharmacological History of Cannabis
Russo, E. B. (2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.003.0002 · Cited by 53
Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain
Mato, S., & Pazos, Á. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.004 · Cited by 53
A review of the safety of selective serotonin reuptake inhibitors during pregnancy
GOLDSTEIN, D. J., & Sundell, K. L. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199907)14:5 · Cited by 19
Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
Bohorquez, S. M. S., Hamill, T. G., Goffin, K. E., Lepeleire, I. D., Bormans, G. M., Burns, H. D., & Laere, K. V. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1340-5 · Cited by 52
Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes
Liu, P., Bilkey, D. K., Darlington, C. L., & Smith, P. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02872-5 · Cited by 52
The Application of 3D-QSAR Studies for Novel Cannabinoid Ligands Substituted at the C1‘ Position of the Alkyl Side Chain on the Structural Requirements for Binding to Cannabinoid Receptors CB1 and CB2
Durdağı, S., Kapou, A., Kourouli, T., Andreou, T., Nikas, S. P., Nahmias, V. R., Papahatjis, D. P., Παπαδόπουλος, Μ. Γ., & Mavromoustakos, T. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0610705 · Cited by 52
The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease
Jain, S., Bisht, A., Verma, K., Negi, S., Paliwal, S., & Sharma, S. K. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3680 · Cited by 53
RETRACTED ARTICLE: Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors
Pietrzak, R. H., Huang, Y. H., Corsi-Travali, S., Zheng, M., Lin, S.-F., Henry, S. E., Potenza, M. N., Piomelli, D., Carson, R. E., & Neumeister, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.110 · Cited by 55
Retracted
Functional connectivity and cannabis use in high-risk adolescents
Houck, J. M., Bryan, A. D., & Feldstein Ewing, S. W. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.837914 · Cited by 50
Cortical thinness and volume differences associated with marijuana abuse in emerging adults
Mashhoon, Y., Sava, S., Sneider, J. T., Nickerson, L. D. H., & Silveri, M. M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.016 · Cited by 50
Drugs of abuse and increased risk of psychosis development
Gururajan, A., Manning, E. E., Klug, M., & van den Buuse, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412455232 · Cited by 50
Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors
Wang, X., Galaj, E., Bi, G., Zhang, C., He, Y., Zhan, J., Bauman, M. H., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14958 · Cited by 53
Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration
Wasserman, A. H., Venkatesan, M., & Aguirre, A. (2020) · Cells · doi:10.3390/cells9061391 · Cited by 50
Targeting the Endocannabinoid System in Alzheimer's Disease
Koppel, J. L., & Davies, P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15315 · Cited by 51
Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
Bassi, M. S., Gilio, L., Maffei, P., Dolcetti, E., Bruno, A., Buttari, F., Centonze, D., & Iezzi, E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00424 · Cited by 51
Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
Grant, I., & Cahn, B. R. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.015 · Cited by 51
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Bernal‐Chico, A., Tepavčević, V., Manterola, A., Utrilla, C. L., Matute, C., & Mato, S. (2022) · Glia · doi:10.1002/glia.24172 · Cited by 50
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling
Basavarajappa, B. S. (2015) · Brain Sciences · doi:10.3390/brainsci5040456 · Cited by 48
Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration?
Lorenzetti, V., Alonso-Lana, S., Youssef, G. J., Verdejo‐García, A., Suo, C., Cousijn, J., Takagi, M., Yücel, M., & Solowij, N. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160805155922 · Cited by 48
Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls
Rentzsch, J., Penzhorn, A., KERNBICHLER, K., Plöckl, D., de Castro, A. G.-C., Gallinat, J., & Jockers-Scherübl, M. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.004 · Cited by 48
Endocannabinoid regulation of relapse mechanisms
Fattore, L., Fadda, P., & Fratta, W. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.004 · Cited by 49
Sleep modulates cannabinoid receptor 1 expression in the pons of rats
Martnez-Vargas, M., Murillo-Rodrguez, E., González‐Rivera, R., Landa, A., Mndez-Daz, M., Prospro-Garca, O., & Navarro, L. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00820-5 · Cited by 48
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Vuić, B., Milos, T., Tudor, L., Konjevod, M., Perković, M. N., Jembrek, M. J., Erjavec, G. N., & Štrac, D. Š. (2022) · Biomedicines · doi:10.3390/biomedicines10123000 · Cited by 49
Cannabinoids Biology: The Search for New Therapeutic Targets
Felder, C. C. (2006) · Molecular Interventions · doi:10.1124/mi.6.3.6 · Cited by 47
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
Leweke, F. M., Mueller, J. K., Lange, B., Fritze, S., Topor, C. E., Koethe, D., & Rohleder, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0539-z · Cited by 48
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Sloan, M. E., Grant, C. W., Gowin, J. L., Ramchandani, V. A., & Foll, B. L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0081-z · Cited by 47
DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2)
Worob, A., & Wenthur, C. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00586 · Cited by 47
Repeated, Intermittent Δ9-Tetrahydrocannabinol Administration to Rats Impairs Acquisition and Performance of a Test of Visuospatial Divided Attention
Verrico, C. D., Jentsch, J. D., Roth, R. H., & Taylor, J. R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300316 · Cited by 47
The endocannabinoid system as a target for modelling psychosis
Koethe, D., Hoyer, C., & Leweke, F. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1591-7 · Cited by 47
Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation
Darmani, N. A., Sim‐Selley, L. J., Martin, B. R., Janoyan, J. J., Crim, J. L., Parekh, B., & Breivogel, C. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02815-7 · Cited by 47
The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
Coelho, M., Duarte, P., Calado, M. S., Almeida, A. J., Reis, C. P., & Gaspar, M. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121838 · Cited by 47
White matter changes in early phase schizophrenia and cannabis use: An update and systematic review of diffusion tensor imaging studies
Cookey, J., Bernier, D. C., & Tibbo, P. G. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.026 · Cited by 45
Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain
Moranta, D., Esteban, S., & Garcı́a-Sevilla, J. A. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0337-0 · Cited by 45
The Emerging Role of the Endocannabinoid System in the Sleep-Wake Cycle Modulation
Murillo‐Rodríguez, E., Poot-Aké, A., Arias-Carrión, Ó., Pacheco-Pantoja, E. L., de la Fuente-Ortegon, A., & Arankowsky‐Sandoval, G. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411798047780 · Cited by 47
In utero Δ9-tetrahydrocannabinol exposure confers vulnerability towards cognitive impairments and alcohol drinking in the adolescent offspring: Is there a role for neuropeptide Y?
Brancato, A., Castelli, V., Lavanco, G., Marino, R. A. M., & Cannizzaro, C. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120916135 · Cited by 47
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Navarro, D., Gasparyan, A., Navarrete, F., Torregrosa, A. B., Rubio, G., Marín, M., Acosta, G. B., García‐Gutiérrez, M. S., & Manzanares, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094764 · Cited by 47
Cannabinoid Type‐1 Receptor Gene Polymorphisms Are Associated with Central Obesity in a Southern Brazilian Population
Jaeger, J. P., Mattevi, V. S., Callegari-Jacques, S. M., & Hutz, M. H. (2008) · Disease Markers · doi:10.1155/2008/841490 · Cited by 45
Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana
Sung, Y., Carey, P. D., Stein, D. J., Ferrett, H. L., Spottiswoode, B. S., Renshaw, P. F., & Yurgelun-Todd, D. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.028 · Cited by 45
Cannabinoid receptor down-regulation in the ventral cochlear nucleus in a salicylate model of tinnitus
Zheng, Y., Baek, J., Smith, P. F., & Darlington, C. L. (2007) · Hearing Research · doi:10.1016/j.heares.2007.01.028 · Cited by 45
Cannabinoid type 1 receptors located on single-minded 1–expressing neurons control emotional behaviors
Dubreucq, S., Kambiré, S. J., Conforzi, M., Metna‐Laurent, M., Cannich, A., Gómez, E. S., Richard, É. M., Marsicano, G., & Chaouloff, F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.049 · Cited by 44
Longitudinal study of hippocampal volumes in heavy cannabis users
Koenders, L., Lorenzetti, V., de Haan, L., Suo, C., Vingerhoets, W. A. M., van den Brink, W., Wiers, R. W. H. J., Meijer, C. J., Machielsen, M. W. J., Goudriaan, A. E., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117718380 · Cited by 44
Cannabis use in youth is associated with limited alterations in brain structure
Scott, J. C., Rosen, A. F. G., Moore, T. M., Roalf, D. R., Satterthwaite, T. D., Calkins, M. E., Ruparel, K., Gur, R. E., & Gur, R. C. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0347-2 · Cited by 44
Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and µ-opioid receptor binding in the basal ganglia
Page, K. J., Besret, L., Jain, M., Monaghan, E., Dunnett, S. B., & Everitt, B. J. (2000) · Experimental Brain Research · doi:10.1007/s002210050016 · Cited by 44
Subregional Hippocampal Thickness Abnormalities in Older Adults with a History of Heavy Cannabis Use
Burggren, A. C., Siddarth, P., Mahmood, Z., London, E. D., Harrison, T. M., Merrill, D. A., Small, G. W., & Bookheimer, S. Y. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0035 · Cited by 43
Neuroimaging of prenatal drug exposure
Dow-Edwards, D. L., Benveniste, H., Behnke, M., Bandstra, E. S., Singer, L. T., Hurd, Y. L., & Stanford, L. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.03.003 · Cited by 43
Drug Testing with Alternative Matrices I. Pharmacological Effects and Disposition of Cocaine and Codeine in Plasma, Sebum, and Stratum Corneum
Joseph, R. E., Oyler, J. M., Wstadik, A. T., Ohuoha, C., & Cone, E. J. (1998) · Journal of Analytical Toxicology · doi:10.1093/jat/22.1.6 · Cited by 43
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Eadie, L., Lo, L. A., Christiansen, A. L., Brubacher, J. R., Barr, A. M., Panenka, W. J., & MacCallum, C. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638962 · Cited by 42
The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain
Weston–Green, K., Huang, X., Han, M., & Deng, C. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008560 · Cited by 42
Synthesis and structure–activity relationships (SARs) of 1,5-diarylpyrazole cannabinoid type-1 (CB1) receptor ligands for potential use in molecular imaging
Donohue, S. R., Halldin, C., & Pike, V. W. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.047 · Cited by 42
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Babayeva, M., & Loewy, Z. G. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040228 · Cited by 44
A novel touch-sensitive apparatus for behavioral studies in unrestrained squirrel monkeys
Kangas, B. D., & Bergman, J. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.06.028 · Cited by 42
7-Alkyl-3-benzylcoumarins: A Versatile Scaffold for the Development of Potent and Selective Cannabinoid Receptor Agonists and Antagonists
Rempel, V., Volz, N., Hinz, S., Karcz, T. P., Meliciani, I., Nieger, M., Wenzel, W., Bräse, S., & Müller, C. E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3008213 · Cited by 41

Authors: Glass, M., Faull, R. L. M., & Dragunow, M.
Affiliations: University of Auckland (NZ)
Corresponding author: Faull, R.L.M
ORCID: Glass, M
Faull, R.L.M
Dragunow, M
Venue: Neuroscience
Publisher: Elsevier BV
Published: 1997-02
Volume: 77
Issue: 2
Pages: 299-318
ISSN: 0306-4522 (ISSN-L)
DOI: 10.1016/s0306-4522(96)00428-9
OpenAlex: W2037811574
Cited by: 1,052
References: 68
Citations by year: 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
FWCI: 11.26
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords: cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
MeSH terms: Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks